Document is current
Any future updates will be listed below
-
Authors
Lo, Yuan-Hung https://orcid.org/0000-0002-9704-3124
Horn, Hudson T.
Huang, Mo-Fan https://orcid.org/0000-0002-2209-1236
Yu, Wei-Chieh https://orcid.org/0000-0001-6844-4845
Young, Chia-Mei https://orcid.org/0009-0002-8846-2340
Liu, Qing
Tomaske, Madeline
Towers, Martina
Dominguez, Antonia
Bassik, Michael C. https://orcid.org/0000-0001-5185-8427
Lee, Dung-Fang https://orcid.org/0000-0003-2387-597X
Qi, Lei S.
Weissman, Jonathan S. https://orcid.org/0000-0003-2445-670X
Chen, Jin https://orcid.org/0000-0002-6634-4397
Kuo, Calvin J. https://orcid.org/0000-0002-7427-5985
- License Information
-
More Information
Article History
Received: 12 October 2024
Accepted: 30 July 2025
First Online: 14 August 2025
Competing interests
: C.J.K. declares outside interest in Surrozen, Inc., Mozart Therapeutics, and NextVivo, Inc. J.S.W. declares outside interest in KSQ Therapeutics, Maze Therapeutics, Chroma Medicine, Amgen, Tessera Therapeutics, 5AM Ventures, and Third Rock Ventures. J.S.W. has filed patent applications related to CRISPRi and CRISPRa screening. J.C. is an employee and shareholder of Altos Labs. The remaining authors declare no competing interests.
